home.social

#phaseii — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #phaseii, aggregated by home.social.

  1. NMD Pharma Reports Topline Phase IIa Results

    NMD Pharma announced data from the SYNAPSE-CMT study evaluating ignaseclant in Charcot-Marie-Tooth disease types 1 and 2. The CIC-1 inhibitor showed consistent functional improvements regarding muscle strength, motor performance, and patient-reported outcomes. Ignaseclant targets the skeletal muscle-specific chloride ion channel 1.

    #biotech #CMT #lifescience #PhaseII